Suppr超能文献

用于治疗哮喘和慢性阻塞性肺疾病的天然产物。

Natural Products for the Management of Asthma and COPD.

作者信息

Liao Wupeng, Tran Quy T N, Peh Hong Yong, Chan Christabel Clare M Y, Fred Wong W S

机构信息

Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, Singapore, Singapore.

Singapore-HUJ Alliance for Research and Enterprise (SHARE), National University of Singapore, Singapore, Singapore.

出版信息

Handb Exp Pharmacol. 2025;287:175-205. doi: 10.1007/164_2024_709.

Abstract

Chronic airway inflammatory diseases like asthma, chronic obstructive pulmonary disease (COPD), and their associated exacerbations cause significant socioeconomic burden. There are still major obstacles to effective therapy for controlling severe asthma and COPD progression. Advances in understanding the pathogenesis of the two diseases at the cellular and molecular levels are essential for the development of novel therapies. In recent years, significant efforts have been made to identify natural products as potential drug leads for treatment of human diseases and to investigate their efficacy, safety, and underlying mechanisms of action. Many major active components from various natural products have been extracted, isolated, and evaluated for their pharmacological efficacy and safety. For the treatment of asthma and COPD, many promising natural products have been discovered and extensively investigated. In this chapter, we will review a range of natural compounds from different chemical classes, including terpenes, polyphenols, alkaloids, fatty acids, polyketides, and vitamin E, that have been demonstrated effective against asthma and/or COPD and their exacerbations in preclinical models and clinical trials. We will also elaborate in detail their underlying mechanisms of action unraveled by these studies and discuss new opportunities and potential challenges for these natural products in managing asthma and COPD.

摘要

像哮喘、慢性阻塞性肺疾病(COPD)这样的慢性气道炎症性疾病及其相关的病情加重会造成巨大的社会经济负担。在有效治疗以控制重度哮喘和COPD进展方面仍然存在重大障碍。在细胞和分子水平上深入了解这两种疾病的发病机制对于开发新疗法至关重要。近年来,人们付出了巨大努力来鉴定天然产物作为治疗人类疾病的潜在药物先导物,并研究它们的疗效、安全性及潜在作用机制。已从各种天然产物中提取、分离出许多主要活性成分,并对其药理功效和安全性进行了评估。对于哮喘和COPD的治疗,已发现并广泛研究了许多有前景的天然产物。在本章中,我们将综述一系列来自不同化学类别的天然化合物,包括萜类、多酚类、生物碱、脂肪酸、聚酮化合物和维生素E,这些化合物在临床前模型和临床试验中已被证明对哮喘和/或COPD及其病情加重有效。我们还将详细阐述这些研究揭示的它们的潜在作用机制,并讨论这些天然产物在管理哮喘和COPD方面的新机遇和潜在挑战。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验